Interpreting serum procalcitonin in COVID-19 patients undergoing renal replacement therapy.

Adams, Briony; Beaney, Alec

Adams, Briony; Beaney, Alec.

Adams B; Core Trainee Year 1 (CT1) Acute Care Common Stem (ACCS) Anaesthetics, Musgrove Park Hospital. Electronic address: brionyadams@outlook.com.
Beaney A; Specialty Registrar Anaesthetics, Stockport NHS Foundation Trust, Stockport, UK.

J Glob Antimicrob Resist ; 27: 324-325, 2021 12.

Article in English | MEDLINE | ID: covidwho-1590860

Subject(s)

COVID-19; Procalcitonin; Anti-Bacterial Agents/therapeutic use; Humans; Renal Replacement Therapy; SARS-CoV-2

Keywords

Antimicrobial; Bacterial; COVID-19; Continuous venovenous haemofiltration; Procalcitonin; Renal replacement therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Procalcitonin / COVID-19 Limits: Humans Language: English Journal: J Glob Antimicrob Resist Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google